Lytix Biopharma AS's market cap is currently €45.53M. The company's EPS TTM is €-0.006299916; its P/E ratio is ―; Lytix Biopharma AS is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
